补肺颗粒治疗哮喘缓解期的临床治疗效果观察

The observation of the clinical efficacy of Bufei particles in the treatment of asthma remission

目的:研究临床治疗哮喘缓解期患者的可靠方法,为哮喘的临床诊治实践提供借鉴和参考依据。方法:选取2012-10/2014-12广东省梅州市梅县区中医院收治的哮喘缓解期患者88例为研究对象,根据患者临床给予治疗方法的不同将其分成了研究组(n=44)和对照组(n=44).研究组给予补肺颗粒治疗,对照组给予补肺颗粒模拟剂治疗,对两组患者的中医喉症评分结果和吸入支气管扩张剂次数进行观察和比较.结果:两组患者治疗前中医喉症评分结果,差异无统计学意义(P>0.05);实施不同治疗后,两组患者的中医喉症评分均得到了显著改善,且治疗前后比较,差异有统计学意义(P<0.05);实施治疗后,两组患者的中医喉症评分结果组间比较,研究组优于对照组,差异有统计学意义(P<0.05);两组患者治疗前吸入支气管扩张剂次数比较,差异无统计学意义(P>0.05);实施不同治疗后,两组患者的吸入支气管扩张剂次数得到了显著改善,且治疗前后比较差异有统计学意义(P<0.05);实施治疗后,两组患者的吸入支气管扩张剂次数组间比较,研究组低于对照组,差异有统计学意义(P<0.05).结论:在临床针对哮喘缓解期患者实施治疗的实践过程中,采用患者补肺颗粒治疗方法的临床治疗效果较好,患者的近远期疗效显著,是应用于临床治疗实践的理想方式之一.

AIM： To study the clinical reliable method for asthma remission,so as to provide reference for the diagnosis and treatment of asthma. METHODS： A total of 88 patients with asthma remission from October 2012 to December 2014 admitted into Meixian Hospital of Traditional Chinese Medicine were chosen as the research objects. According to the differences of clinical treatment method,they were divided into the study group and the control group,with 44 cases in each group. The study group was given Bufei particles for treatment,and the control group was given simulant of Bufei particles. The Traditional Chinese Medicine laryngomalacia score results and the number of agents on inhaled bronchodilators for the two groups were observed and compared. RESULTS： The differences of TCM laryngomalacia score results before treatment between the two groups were not significant,and there were no statistically significant difference（ P〉0.05）. After the implementation of different treatment,the Traditional Chinese Medicine laryngomalacia scores were significantly improved. The differences before and after treatment were statistically significant（ P〈0. 05）. After the implementation of treatment,the TCM laryngomalacia score results between the two groups,in which the study group was better than the control group,had statistical significant difference（ P〈0.05）. The differences of the number of agents inhaled bronchodilators before treatment were not significant,and they were no statistical significant（ P〉0.05）. After the implementation of different treatment,the number of agents inhaled bronchodilators had been significantly improved,and the differences before and after treatment were statistically significant（ P〈0. 05）. After the implementation of treatment,the number of agents inhaled bronchodilators between the two groups,in which the study group was lower than the control group,had statistically significant difference（ P〈0. 05）.CONCLUSION： In clinical practice for the treatment of asthma in remission for patients,the clinical effect of the application of Bufei particle therapy is better,the recent and long-term efficacy in patients is remarkable,and it is the ideal way to apply in clinical practice.